Researchers create intravaginal ring using MPT to protect women from HIV and unintended pregnancy

A new intravaginal ring has been developed for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus drug and a contraceptive.

http://www.news-medical.net/news/20131113/Researchers-create-intravaginal-ring-using-MPT-to-protect-women-from-HIV-and-unintended-pregnancy.aspx